Notice of Correction to Key Dates for PAR-19-345 "NIDA Program Project Grant Applications (P01 Clinical Trial Optional)"

Notice Number: NOT-DA-19-071

Key Dates
Release Date: August 28, 2019

Related Announcements
PAR-19-345

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform potential applicants of correction to the AIDS application receipt date for PAR-19-345 " NIDA Program Project Grant Applications (P01 Clinical Trial Optional)". A due date for AIDS applications for January 2020 Council has been added; this new AIDS date is September 30, 2019. The remaining due dates are unchanged. The due dates for May 2020 council remain September 25, 2019 (non-AIDS applications) and January 7, 2020, (AIDS applications).

The FOA has been modified as follows:

Part 1. Overview Information

Key Dates

Currently Reads:

AIDS Application Due Date(s)

The first AIDS application due date for this FOA is January 7, 2020

Modified to Read:

AIDS Application Due Date(s)

The first AIDS application due date for this FOA is September 30, 2019. Following this date, standard dates apply.

** Please note, this receipt date (September 30, 2019) for AIDS applications will go to January 2020 Council and beyond that standard dates apply.**

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kevin Walton, Ph.D.
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse(NIDA)
Telephone: 301-827-5980
Email: waltonkm@nida.nih.gov

Meyer D. Glantz, Ph.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: mglantz@nida.nih.gov

Jonathan D. Pollock, Ph.D.
Division of Neuroscience and Behavior
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1316
Email: npilotte@mail.nih.gov

Steven Grant, Ph.D.
Division of Neuroscience and Behavior
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-4877
Email: sgrant@nida.nih.gov